---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-019415"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:43:52.947114+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Orchestra BioMed confirms SVB exposure less than 1% of total cash

## Summary
- Less than 1% of total cash, cash equivalents and marketable securities held at Silicon Valley Bank.
- Company states exposure to SVB is de minimis and not material.
- Filed investor slide presentation for Q1 2023; no material new disclosures beyond SVB update.

## SEC filing metadata
- accession: 0001213900-23-019415
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000121390023019415/0001213900-23-019415-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000121390023019415/ea175052-8k_orchestra.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-019415
- JSON: https://secwatch.observer/filing/0001213900-23-019415.json
- Plain text: https://secwatch.observer/filing/0001213900-23-019415.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.